Entrada Therapeutics Inc (TRDA)
SG&A Expenses
$10.49M
Quarterly · Period ending: · USD
TRDA SG&A Expenses
Latest reported$10.49Mperiod ending
Latest reported$10.49Mperiod ending
TRDA Quarterly SG&A Expenses ($1.15M → $10.49M)
Quarterly SG&A Expenses
High-resolution chart · PNG
TRDA sg&a expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 10,492,000 | |
| 10,124,000 | |
| 9,550,000 | |
| 10,304,000 | |
| 10,922,000 | |
| 10,274,000 | |
| 9,859,000 | |
| 9,971,000 | |
| 9,236,000 | |
| 9,399,000 | |
| 8,652,000 | |
| 7,532,000 | |
| 8,169,000 | |
| 7,938,000 | |
| 9,894,000 | |
| 6,978,000 | |
| 7,334,000 | |
| 6,433,000 | |
| 6,098,000 | |
| 3,851,000 | |
| 3,081,000 | |
| 2,170,000 | |
| 1,997,000 | |
| 1,273,000 | |
| 1,147,500 | |
| 1,147,500 |